2024 annual financial data
Adial Pharmaceuticals 2024 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -8,284,457 USD and net income was -13,197,451 USD.
Operating cash flow was -6,922,306 USD.
Get free Adial Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,284,457 USD
- Net income
- -13,197,451 USD
- Operating cash flow
- -6,922,306 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Adial Pharmaceuticals financial years